serial,sid,uuid,token,uri,created,completed,changed,in_draft,current_page,remote_addr,uid,langcode,webform_id,entity_type,entity_id,locked,sticky,notes,first_name,last_name,email,phone,gyn_program,institution,career_stage,consider_for_oral_presentation_,abstract_title,first_name_author1,last_name_author1,affiliation_author1,additional_authors_list,topic_classification,upload_abstract_1,special_characters_included_,abstract_review_status
1,1,eba27536-3bf9-4185-b287-a1f3de2da097,z1ZRlXwxBW2PD_tYglYpIqFHVeam2XURvINhz67Mwt8,/dctd/gynsporemeeting/abstract,1703242946,1730150302,1734865346,,,174.189.237.106,767,en,gyn_spore_abstracts,node,1753,,,,George,Lennon,test@test.com,098-765-4321,Oratione,Dixisset,ESI,Yes,"Quae cum dixisset, finem ille. Quamquam non negatis nos intellegere quid sit voluptas, sed quid ille dicat. Progredientibus autem aetatibus sensim tardeve potius quasi nosmet ipsos cognoscimus. Gloriosa ostentatio in constituendo summo bono. Qui-vere falsone, quaerere mittimus-dicitur oculis se privasse; Duarum enim vitarum nobis erunt instituta capienda. Comprehensum, quod cognitum non habet? Qui enim existimabit posse se miserum esse beatus non erit. Causa autem fuit huc veniendi ut quosdam hinc libros promerem. Nunc omni virtuti vitium contrario nomine opponitur.",John,Starr,Loremipsum,"[{ first_name: John, last_name: McCartney, affiliation: Dixisset }, { first_name: George, last_name: Starr, affiliation: Loremipsum }, { first_name: John, last_name: Starr, affiliation: Dixisset }]","Session 3: DNA repair and PARP inhibition,Session 2: Combination therapies and Immunotherapy,Session 5: Tumor biology%2C early detection%2C and prevention",https://events.cancer.gov/sites/default/files/webform/gyn_spore_abstracts/_sid_/upload_abstract_1.docx,1,"Approved to be a Speaker"
2,2,5da5dc86-1678-4d1d-809e-32a7ef773aa6,Ndefs53DOBUDKMf4DOM8ssxtHZcRdJtp77l9YJZ6v7g,/dctd/gynsporemeeting/abstract,1703242946,1713942621,1734865346,,,123.163.213.8,1083,en,gyn_spore_abstracts,node,1753,,,,Paul,Starr,test@test.com,123-456-7890,Loremipsum,Loremipsum,"Graduate Student",No,"Huius, Lyco, oratione locuples, rebus ipsis ielunior. Duo Reges: constructio interrete. Sed haec in pueris; Sed utrum hortandus es nobis, Luci, inquit, an etiam tua sponte propensus es? Sapiens autem semper beatus est et est aliquando in dolore; Immo videri fortasse. Paulum, cum regem Persem captum adduceret, eodem flumine invectio? Et ille ridens: Video, inquit, quid agas;",George,McCartney,Dixisset,"[{ first_name: John, last_name: McCartney, affiliation: Loremipsum }, { first_name: George, last_name: McCartney, affiliation: Loremipsum }, { first_name: Ringo, last_name: McCartney, affiliation: Loremipsum }]","Session 5: Tumor biology%2C early detection%2C and prevention,Session 3: DNA repair and PARP inhibition,Session 6: Translating Innovation to Clinical trials",https://events.cancer.gov/sites/default/files/webform/gyn_spore_abstracts/_sid_/upload_abstract_1.docx,1,"Approved to be a Speaker"
3,3,b1cfc6cd-013f-4ef8-a507-7cfbaed5b3e8,ca07Lz0rXEGhtWVBJNv3E5gqRmZcRU08wmsUKvT8bDc,/dctd/gynsporemeeting/abstract,1703242946,1710105239,1734865346,,,155.150.153.85,1075,en,gyn_spore_abstracts,node,1753,,,,Paul,Lennon,random@random.com,098-765-4321,Loremipsum,Oratione,"Graduate Student",No,"Quae cum dixisset, finem ille. Quamquam non negatis nos intellegere quid sit voluptas, sed quid ille dicat. Progredientibus autem aetatibus sensim tardeve potius quasi nosmet ipsos cognoscimus. Gloriosa ostentatio in constituendo summo bono. Qui-vere falsone, quaerere mittimus-dicitur oculis se privasse; Duarum enim vitarum nobis erunt instituta capienda. Comprehensum, quod cognitum non habet? Qui enim existimabit posse se miserum esse beatus non erit. Causa autem fuit huc veniendi ut quosdam hinc libros promerem. Nunc omni virtuti vitium contrario nomine opponitur.",John,Lennon,Loremipsum,"[{ first_name: Ringo, last_name: Lennon, affiliation: Dixisset }, { first_name: John, last_name: Harrison, affiliation: Loremipsum }, { first_name: John, last_name: Harrison, affiliation: Oratione }]","Session 6: Translating Innovation to Clinical trials,Session 2: Combination therapies and Immunotherapy,Session 3: DNA repair and PARP inhibition",https://events.cancer.gov/sites/default/files/webform/gyn_spore_abstracts/_sid_/upload_abstract_1.docx,1,"Approved to be a Poster Presenter"